๐ฐ Lead Author News
Page 50 - Lead Author News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lead Author. Real-time updates on events, politics, business and more.
March 24, 2022
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress, 30 March-2 April 2022.
March 22, 2022
The 2022 State of Cyber Assets Report (2022 SCAR) conducted by JupiterOne, the industryโs leading cyber asset attack surface management (CAASM) (...)
March 21, 2022
Putin has shown us we can no longer safely rely on imported oil. This is a wake-up call to electrify our transport systems and our government can lead the way.
March 18, 2022
In a commentary, SMU Associate Professor of Science, Technology and Society Winston Chow explained the outsized risks and opportunities for coastal cities like Singapore in a warming world. He also warned that the window for climate action is rapidly closing, and he shared about how building climate-resilient communities can address the climate change issue and secure a liveable future. Assoc Prof Chow is Lead Author in the Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report...
March 8, 2022
Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher.
March 8, 2022
When we eat food, our gut somehow senses its presence to begin shifting it along our digestive tract, but the question has always been โ how?
March 5, 2022
A new study has found that artificial intelligence (AI) apps helped protect small and medium-sized businesses against many of the risks that emerged during the COVID-19 pandemic โ yet only a quarter of small firms currently use them.
March 4, 2022
Michael E Mannโs profile on The Conversation
March 3, 2022
An anti-inflammatory drug candidate, known as 3,6โ-dithiopomalidomide (DP), designed by researchers at the National Institute on Aging (NIA), protected
February 28, 2022
Edward R. Carrโs profile on The Conversation